Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease

Neuroscience Letters

Volumn 550, Issue , 2013, Pages 64-68

  Kim, Hengjun J ^a,b   Kim, Sang Joon ^a   Kim, Ho Sung ^a   Choi, Choong Gon ^a   Kim, Namkug ^a   Han, Seungbong ^a   Jang, Eun Hye ^a   Chung, Sun J ^a   Lee, Chong Sik ^a  

^a University of Ulsan   (South Korea)

^b Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Diffusion tensor imaging (DTI); Mean diffusivity (MD); Parkinson's disease (PD)

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; EXTERNAL CAPSULE; FEMALE; GLOBUS PALLIDUS; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN DIFFUSIVITY; NERVOUS SYSTEM PARAMETERS; PARKINSON DISEASE; PRECUNEUS; PRIORITY JOURNAL; PUTAMEN; STRIA TERMINALIS; SUPRAMARGINAL GYRUS; THALAMUS; UNCINATE FASCICULUS; WHITE MATTER;

DIFFUSION TENSOR IMAGING; DIFFUSION TENSOR IMAGING (DTI); DIFFUSION-WEIGHTED IMAGE; DTI; DWI; FA; FAMILY-WISE ERROR; FMRIB SOFTWARE LIBRARY; FRACTIONAL ANISOTROPY; FSL; FWE; MD; MEAN DIFFUSIVITY; MEAN DIFFUSIVITY (MD); PARKINSON'S DISEASE; PARKINSON'S DISEASE (PD); PD; REGION-OF-INTEREST; ROI; TBSS; TRACT-BASED SPATIAL STATISTICS;

AGED; BRAIN; BRAIN MAPPING; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; NERVE FIBERS, UNMYELINATED; NEUROIMAGING; PARKINSON DISEASE;

EID: 84881376782     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.06.050     Document Type: Article

References (34)

1. Agosta F., Canu E., Stojković T., Pievani M., Tomić A., Sarro L., Dragašević N., Copetti M., Comi G., Kostić V.S., Filippi M. The topography of brain damage at different stages of Parkinson's disease. Human Brain Mapping 2012, 10.1002/hbm.22101.
2. Bohnen N.I., Müller M.L., Koeppe R.A., Studenski S.A., Kilbourn M.A., Frey K.A., Albin R.L. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology 2009, 73:1670-1676.
3. Braak H., Del Tredici K., Rüb U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging 2003, 24:197-211.
4. Brooks D.J. Technology insight: imaging neurodegeneration in Parkinson's disease. Nature Clinical Practice Neurology 2008, 4:267-277.
5. Calabresi P., Picconi B., Parnetti L., Di Filippo M. A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. Lancet Neurology 2006, 5:974-983.
6. Calne D.B., Langston J.W., Martin W.R., Stoessl A.J., Ruth T.J., Adam M.J., Pate B.D., Schulzer M. Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease. Nature 1985, 317:246-248.
7. Chan L.L., Rumpel H., Yap K., Lee E., Loo H.V., Ho G.L., Fook-Chong S., Yuen Y., Tan E.K. Case control study of diffusion tensor imaging in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 2007, 78:1383-1386.
8. Chaudhuri K.R., Healy D.G., Schapira A.H. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurology 2006, 5:235-245.
9. Chiang M.C., Barysheva M., Shattuck D.W., Lee A.D., Madsen S.K., Avedissian C., Klunder A.D., Toga A.W., McMahon K.L., de Zubicaray G.I., Wright M.J., Srivastava A., Balov N., Thompson P.M. Genetics of brain fiber architecture and intellectual performance. Journal of Neuroscience 2009, 29:2212-2224.
10. Chu Y., Morfini G.A., Langhamer L.B., He Y., Brady S.T., Kordower J.H. Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease. Brain 2012, 135:2058-2073.
11. Focke N.K., Yogarajah M., Bonelli S.B., Bartlett P.A., Symms M.R., Duncan J.S. Voxel-based diffusion tensor imaging in patients with mesial temporal lobe epilepsy and hippocampal sclerosis. Neuroimage 2008, 40:728-737.
12. Folstein M.F., Folstein S.E., McHugh P.R., Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
13. Gattellaro G., Minati L., Grisoli M., Mariani C., Carella F., Osio M., Ciceri E., Albanese A., Bruzzone M.G. White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. American Journal of Neuroradiology 2009, 30:1222-1226.
14. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Archives of Neurology 1999, 56:33-39.
15. Gibb W.R., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 1988, 51:745-752.
16. Hely M.A., Morris J.G., Reid W.G., Trafficante R. Sydney multicenter study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Movement Disorders 2005, 20:190-199.
17. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
18. Karagulle Kendi A.T., Lehericy S., Luciana M., Ugurbil K., Tuite P. Altered diffusion in the frontal lobe in Parkinson disease. American Journal of Neuroradiology 2008, 29:501-505.
19. Kishore A., Popa T., Velayudhan B., Joseph T., Balachandran A., Meunier S. Acute dopamine boost has a negative effect on plasticity of the primary motor cortex in advanced Parkinson's disease. Brain 2012, 135:2074-2088.
20. la Fougère C., Zwergal A., Rominger A., Förster S., Fesl G., Dieterich M., Brandt T., Strupp M., Bartenstein P., Jahn K. Real versus imagined locomotion: a [18F]-FDG PET-fMRI comparison. Neuroimage 2010, 50:1589-1598.
21. Lang A.E., Lozano A.M. Parkinson's disease. First of two parts. New England Journal of Medicine 1998, 339:1044-1053.
22. D.Le Bihan Looking into the functional architecture of the brain with diffusion MRI. Nature Reviews Neuroscience 2003, 4:469-480.
23. Lee C.S., Samii A., Sossi V., Ruth T.J., Schulzer M., Holden J.E., Wudel J., Pal P.K., de la Fuente-Fernandez R., Calne D.B., Stoessl A.J. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Annals of Neurology 2000, 47:493-503.
24. Lehéricy S., Ducros M., Van de Moortele P.F., Francois C., Thivard L., Poupon C., Swindale N., Ugurbil K., Kim D.S. Diffusion tensor fiber tracking shows distinct corticostriatal circuits in humans. Annals of Neurology 2004, 55:522-529.
25. Mori S., Oishi K., Jiang H., Jiang L., Li X., Akhter K., Hua K., Faria A.V., Mahmood A., Woods R., Toga A.W., Pike G.B., Neto P.R., Evans A., Zhang J., Huang H., Miller M.I., van Zijl P., Mazziotta J. Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. Neuroimage 2008, 40:570-582.
26. Nichols T.E., Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Human Brain Mapping 2002, 15:1-25.
27. Nicoletti G., Lodi R., Condino F., Tonon C., Fera F., Malucelli E., Manners D., Zappia M., Morgante L., Barone P., Barbiroli B., Quattrone A. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain 2006, 129:2679-2687.
28. Péran P., Cherubini A., Assogna F., Piras F., Quattrocchi C., Peppe A., Celsis P., Rascol O., Démonet J.F., Stefani A., Pierantozzi M., Pontieri F.E., Caltagirone C., Spalletta G., Sabatini U. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain 2010, 133:3423-3433.
29. Playford E.D., Jenkins I.H., Passingham R.E., Nutt J., Frackowiak R.S., Brooks D.J. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Annals of Neurology 1992, 32:151-161.
30. Rae C.L., Correia M.M., Altena E., Hughes L.E., Barker R.A., Rowe J.B. White matter pathology in Parkinson's disease: the effect of imaging protocol differences and relevance to executive function. Neuroimage 2012, 62:1675-1684.
31. 15O PET study. NeuroReport 2001, 12:821-828.
32. Selden S.R., Gitelman D.R., Salamon-Murayama N., Parrish T.B., Mesulam M.M. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain 1998, 121:2249-2257.
33. Smith S.M., Jenkinson M., Johansen-Berg H., Rueckert D., Nichols T.E., Mackay C.E., Watkins K.E., Ciccarelli O., Cader M.Z., Matthews P.M., Behrens T.E. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006, 31:1487-1505.
34. Song S.K., Sun S.W., Ju W.K., Lin S.J., Cross A.H., Neufeld A.H. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 2003, 20:1714-1722.